Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.

MLA

Zhong, Liting, et al. “Recurrent Gallbladder Carcinoma With PMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.” Frontiers in Oncology, vol. 11, Jan. 2022, pp. 1–5. EBSCOhost, https://doi.org/10.3389/fonc.2021.783158.

APA

Zhong, L., Liu, X., Li, Z., Zhang, X., Wang, Y., & Peng, W. (2022). Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report. Frontiers in Oncology, 11, 1–5. https://doi.org/10.3389/fonc.2021.783158

Chicago

Zhong, Liting, Xiaoyu Liu, Zelei Li, Xuebing Zhang, Yuli Wang, and Weiwei Peng. 2022. “Recurrent Gallbladder Carcinoma With PMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.” Frontiers in Oncology 11 (January): 1–5. doi:10.3389/fonc.2021.783158.